Being on Mounjaro is no joke – I had the most embarrassing side effect & ended up on a corner shop loo…but it gets worse
Despite being 'really happy' with losing two to three lbs a week on the injections, Megan Craze, who is from Wales, recently shared all on her most embarrassing side effect.
3
3
Not only did the brunette find herself on the loo in a local corner shop where the staff could hear everything, but that wasn't the worst of it.
Posting on social media, Megan, who has lost over 16lbs in four weeks on fat jabs, claimed that bowel movements on Mounjaro are "no joke,' as she opened up on "the worst experience on Monjaro."
Being brutally honest, Megan said: 'I was out driving like I normally do, I was about half an hour away from home and I had no warning and oh my god, I needed to s**t.
'It was one of those s***s that if you don't go, you're gonna s**t yourself.'
Mounjaro, which is known as the King Kong of jabs, is now being prescribed on the NHS in the first anti-obesity rollout of its kind.
It is said to suppress the appetite, making people feel fuller for longer.
Such injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese - with a Body Mass Index of 30 or over.
One jab is administered each week but the duration is dependent on a person's weight.
Many Mounjaro users have been candid on experiencing diarrhoea whilst using the jabs - and this is exactly what happened to Megan.
After experiencing a strong urge to go to the toilet whilst driving, the content creator admitted that she pulled over and desperately ran into the first corner shop she could see.
And after begging a staff member if she could use their loo, thankfully he agreed.
But what happened next left Megan mortified, as she confessed that the staff member could hear everything.
She explained: "No joke - the toilet of the corner shop was literally right next to the counter and he could hear me s******g.
'I felt so awkward, I could have literally swallowed the ground up.'
But that wasn't the worst of Megan's embarrassing experience, as just moments later, she found herself in a very similar, but somewhat worse situation.
She shared: 'After that, I got back in the car, travelled another 10 minutes and I had that feeling again - I had to pull over and run into a pub and what made it even worse about the pub was the toilets were so close to the bar, the bar could hear me s******g and they were laughing at me.'
Reflecting on the awkward 'disaster,' Megan begged her followers to not 'laugh' at her.
Mounjaro users react
The TikTok clip, which was posted under the username @ megancraze01, has clearly left many open-mouthed, as it has quickly racked up 52,500 views.
Not only this, but it's also amassed 534 likes, 100 comments and 200 shares in just two days.
But it's not just Megan suffering with unfortunate bowel movements, as numerous Mounjaro users raced to the comments to share their similar experiences.
One person said: 'This is me!!!! It goes ALL DAY.'
Another added: 'I had this so badly I passed out, fell off the toilet and smacked my head on the floor.'
A third commented: 'Ahh this happened to me Sunday and today!! And I'm not joking, the smell! I've also got sulphur burps!'
Meanwhile, one user wrote: 'That can not be healthy for you, I'd stop using it and try different ways to lose weight if that's your goal. Healthy diet in a calorie deficit and exercise will help you.'
But to this, Megan fumed and clapped back: 'Why don't you mind your business and leave me to do my own thing? You're a literal stranger, why are you so bothered?'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
At the same time, other Mounjaro users opened up about experiencing constipation whilst using the jabs.
One user admitted: 'I can't even poop on mine.'
A second confessed: 'I wish I had this!!! I'm completely backed up! Have been since I started!'
Whilst someone else acknowledged: 'I'm the opposite. Haven't gone in over a week.'
The reality of fat jabs
Not only have many dealt with mortifying side effects whilst using Mounjaro, but last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight.
A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
The common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration.
And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas.
Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic.
The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'.
Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.
'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
25 minutes ago
- BBC News
Nurses' views should be heard - Jersey's health minister says
Nurses should have more say over the future of the health service, Jersey's health minister has said. Deputy Tom Binet said that nurses have an important contribution to make as the "people who are hands-on". It comes after he met with Nicola Ranger, chief executive of the Royal College of Nursing (RCN), who visited the island on Wednesday and said it was "vital" for nurses to sit in during senior to her comments, Binet agreed, stating: "As a principle, I think it is extremely good and I think it's something we should be adopting even more than we are doing already." Ms Ranger described her visit and meeting with Binet as positive, adding that she felt her "message was really heard".Binet said: "I've been in business for many years, and I've found as the organisation gets bigger, by going back to the ground floor, you can often find out where the problems are."
Telegraph
25 minutes ago
- Telegraph
We'll use AI to spot more prostate cancer, says Science Secretary
Artificial Intelligence will be harnessed to find hidden cases of prostate cancer, the Science Secretary has said. Peter Kyle told The Telegraph that the Government is investing £168m on initiatives to use public data better and one major goal is to improve cancer screening on the NHS. A world-leading initiative led by Cancer Research UK has been given £10m in funding to improve cancer screening methods by identifying the most at-risk people and offering them personalised tests. The funding will 'develop AI-powered tools that can predict cancer risk', Mr Kyle said, and could save thousands of lives a year. The Telegraph has launched a campaign calling for a targeted national screening programme for prostate cancer, which focusses on men who are at the greatest risk. This includes men over 50, black men, whose risk is twice that of white men, and those with a family history of prostate cancer. Steve McQueen, Bob Willis and Chris Hoy are some of the high-profile British men to be recently diagnosed with the condition. Around 55,000 men are diagnosed with prostate cancer annually in England and around 33 men a day die from the condition. Writing for The Telegraph alongside Stian Westlake, the executive chairman of the Economic and Social Research Council, Mr Kyle said: 'This funding will support work on a project linking health records to demographics, family history and behaviour to identify those at higher risk of this devastating illness, so that it can be treated early – potentially saving thousands of lives every year.' The plan is to create flexible national screening programmes which can pick up more cases in individuals who may otherwise be missed and diagnosed only when the cancer was incurable. Officials are hoping to replicate the success of BRCA1 genetic screening. Around one in 400 people has faulty BRCA genes, which give women a 60 per cent chance of developing breast cancer. This received widespread attention and became known as the 'Angelina Jolie gene' after the Hollywood actress underwent a double mastectomy after finding out she was a carrier in 2013. The NHS now offers genetic tests to high-risk groups, such as Jewish women, to catch as many cases early as possible. Mr Kyle said: 'Just as BRCA gene screening, heroically brought to the fore by campaigners including Angelina Jolie, revolutionised how we understand and manage the risk of hereditary breast cancer, this next generation of data-driven screening could do the same for more cancers, including prostate cancer.' Scientists running the scheme hope it can enable the NHS to offer more frequent cancer screening sessions or screening at a younger age to those at higher risk, while those at lower risk could be spared unnecessary tests. People identified as higher risk could also be sent for cancer testing faster when they go to their GP with possible symptoms. The wider Administrative Data Partnership will last until 2031 and try to repurpose data that already exists to make improvements to the judicial service, education, health and other public sectors. Combining, standardising and interpreting different datasets simultaneously is a daunting challenge for scientists owing to decades of independent data collection and little crossover. However, the Government believes that vast data reserves, combined with the power of AI computing, could transform healthcare. The cancer screening project will build new models over the next five years to merge relevant data as well as creating algorithms which will process it and ensure the results are accurate and reliable. Antonis Antoniou, the programme director and professor of cancer risk prediction at the University of Cambridge, said: 'The UK's strengths in population-scale data resources, combined with advanced analytical tools like AI, offer tremendous opportunities to link disparate datasets and uncover clues that could lead to earlier detection, diagnosis, and prevention of more cancers.' Dr David Crosby, the head of prevention and early detection research at Cancer Research UK, told The Telegraph: 'The single most important thing we can do to beat cancer is to find it earlier, when treatment is more likely to be successful. 'With half a million cancer cases per year expected in the UK by 2040, we need a major shift towards more accurate diagnosis and detection of early cancer. 'The Cancer Data Driven Detection programme will link health data sources together and build the powerful new tools doctors need to identify those at highest risk of cancer and prioritise resources towards them. 'Moving towards a preventative approach to healthcare will not be easy and will take time. Cancer Research UK's investment in the programme is an investment in the future of cancer care.' Data is the key to changing lives for the better By Peter Kyle and Stian Westlake For much of our everyday lives, data is king – from digital maps getting us from A to B, to health apps keeping our fitness and sleep in check, to even streaming platforms suggesting the next drama we might want to get stuck into. For this government, making good use of data is the difference between successful policies that are rooted in evidence, and those that rely on hope, luck or intuition, which no minister, legislator or council leader wants to rely on. Ultimately data is the bedrock of decision-making, ensuring policies, programmes and funding are doing what they are intended to do – changing lives for the better. Linking data from across government to the national pupil database for example can help to really dig into the source of inequalities that trap too many Brits from childhood through to the labour market – helping us to take targeted action in boosting social mobility and shattering glass ceilings. Or by better applying it in the justice system, we can understand patterns of reoffending, stopping career criminals from inflicting more misery on the law-abiding majority. And it can forecast the impact that this government extending the national living wage has on younger workers, so that millions more who put the hours in take home the pay they deserve. What unites all of these examples is that they were all made possible by UKRI's administrative data research UK partnership. It works to connect, and make sense of, the huge wealth of data that is generated by government services, bringing it to our world class researchers securely and with the public's privacy at heart since 2018. In short it has been demonstrating the role data can play in improving lives in as many ways as we can imagine and more. But we know we can go further and too many social and economic researchers – many of the very best of whom are right here in the UK – simply can't access the data they need. It is fragmented and siloed, held in different datasets by different public organisations. That means too many rely instead on insights from abroad, which while offering much, simply can't tell the full story of life in Britain in 2025. Accessing the raw resource of all that data and translating it into a form that researchers can use is no easy task, and while we need to grow our data science expertise, we also need to build relationships and make the case to other organisations that secure data sharing has the power to change lives. That is why UKRI is investing a further £168m to continue ADR UK's programme of work through to 2031. This includes continuing our partnership with Cancer Research UK to develop AI-powered tools that can predict cancer risk based on health records, family history and behaviour. Just as BRCA gene screening, heroically brought to the fore by campaigners including Angelina Jolie, revolutionised how we understand and manage the risk of hereditary breast cancer, this next generation of data-driven screening could do the same for more cancers, including prostate cancer. This funding will support work with organisations and charities like Cancer Research UK for example, on a project linking health records to demographics, family history, and behaviour to identify those at higher risk of this devastating illness, so that it can be treated early – potentially saving thousands of lives every year. The ADR will also offer learnings for and help us shape our new national data library, a central government resource designed to bring together existing research programmes and make it easier for policymakers and public bodies to access and use data securely to improve public services. As the incredible opportunities and challenges of technology like AI advance at unprecedented speeds and as we grapple with the fate of our planet as our climate changes, using data to drive policy for the generations to come has never been more important. This government is driven by a plan for change that will transform the lives of the British people, from growing our economy so that our payslips go further, to unlocking opportunity for everyone regardless of background, and building an NHS that is fit for the future and makes the most of the opportunities in new technology. Data can play a huge part in getting that right and targeting government support where it is needed most.
Telegraph
25 minutes ago
- Telegraph
‘One tiny scratch from rabid puppy killed mum'
The daughter of a British woman who died of rabies after she was scratched by a puppy on holiday in Morocco has revealed the 'horrendous' symptoms she suffered. Yvonne Ford went months without realising she had been infected by a puppy that was underneath her sunbed in February, said her daughter Robyn Thomson, 32. Ms Ford, 59, from Barnsley, started suffering from a 'horrendous' headache and was admitted to hospital four months later. Within days, she could not walk, talk, sleep or swallow. She started hallucinating and developed a fear of water, classic symptoms of rabies. The grandmother of four was transferred from Barnsley to Royal Hallamshire Hospital in Sheffield where she was eventually diagnosed with rabies. She died on June 11. Her daughter, a neonatal nurse, said: 'There was no blood and no evidence of the dog being unwell. 'It was such a mild scratch and it never got infected so we just thought nothing of it at the time. Mum came home and everything was normal. We went to Florida as a family and she went fishing with my dad.' In June, the symptoms began and she 'came down with this horrendous headache'. She added: 'Soon, she couldn't sleep, she couldn't walk, she couldn't talk. She was hallucinating and had a fear of water. 'She couldn't swallow. She was choking on her own saliva. So doctors put her in an induced coma.' The UK Health Security Agency has warned that holidaymakers should exercise caution around animals in countries where the disease is present. Egypt, Turkey and Albania are among the destinations that the Government has ascribed as 'high risk'. It advises that all visitors to rabies-affected countries 'should avoid contact with dogs, cats and other animals wherever possible, and seek advice about the need for rabies vaccine prior to travel'. Costa Rica, Bali, Mexico, Vietnam and South Africa are also rated 'high risk'. It took a week for Ms Ford to be diagnosed. 'There's only one outcome for rabies once symptoms develop and it's death every time. So we had to turn off her life support,' said her daughter. Ms Ford's family later found out that it normally takes a few months for rabies symptoms to show – but the disease can incubate for up to two years. She added: 'Mum was the most loving person imaginable. She was a huge animal lover so for her to have died of rabies, it is just particularly horrendous.' Now, Ms Thomson wants to spread awareness and help stop it at the source via a charity mission in Cambodia. She is flying out to the south-east Asian country this October to volunteer with Mission Rabies – an award-winning charity that leads mass dog vaccination campaigns, rabies surveillance and vital community education across Asia and Africa. Their goal is to vaccinate at least 70 per cent of the dog population to achieve herd immunity and stop rabies at its source, while also educating children on how to recognise rabid animals and stay safe. To volunteer with Rabies Mission, Ms Thomson needs to raise money to cover the cost of travel, accommodation and project fees. She said: 'This is something I need to do. If I can save even one life through this work, or spare one family from going through the pain we have experienced, then it will be turning a terrible negative into something positive. 'I'm determined to transform my grief into action – helping vaccinate dogs, support surveillance efforts and deliver life-saving lessons in schools.'
